Company research / ANIK
Anika Therapeutics, Inc. (ANIK)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Anika Therapeutics, Inc. reported revenue of $112.82M. Revenue fell 5.9% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $120.65M.
Key ratios (year ended 2025-12-31)
56.6%
Gross margin
-9.8%
Operating margin
-9.6%
Net margin
-7.6%
Return on year-end equity
-5.9%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.